A critical review on experimental Streptococcus suis infection in pigs with a focus on clinical monitoring and refinement strategies.

Publisher: BioMed Central Country of Publication: England NLM ID: 101249759 Publication Model: Electronic Cited Medium: Internet ISSN: 1746-6148 (Electronic) Linking ISSN: 17466148 NLM ISO Abbreviation: BMC Vet Res Subsets: MEDLINE

Original Publication: London : BioMed Central, 2005-

Streptococcus suis* ; Swine Diseases*/pathology ; Streptococcal Infections*/veterinary; Animals ; Swine ; Body Temperature

Streptococcus suis (S. suis) is a major pig pathogen worldwide with zoonotic potential. Though different research groups have contributed to a better understanding of the pathogenesis of S. suis infections in recent years, there are still numerous neglected research topics requiring animal infection trials. Of note, animal experiments are crucial to develop a cross-protective vaccine which is highly needed in the field. Due to the severe clinical signs associated with S. suis pathologies such as meningitis and arthritis, implementation of refinement is very important to reduce pain and distress of experimentally infected pigs. This review highlights the great diversity of clinical signs and courses of disease after experimental S. suis pig infections. We review clinical read out parameters and refinement strategies in experimental S. suis pig infections published between 2000 and 2021. Currently, substantial differences exist in describing clinical monitoring and humane endpoints. Most of the reviewed studies set the body temperature threshold of fever as high as 40.5°C. Monitoring intervals vary mainly between daily, twice a day and three times a day. Only a few studies apply scoring systems. Published scoring systems are inconsistent in their inclusion of parameters such as body temperature, feeding behavior, and respiratory signs. Locomotion and central nervous system signs are more common clinical scoring parameters in different studies by various research groups. As the heterogenicity in clinical monitoring limits the comparability between studies we hope to initiate a discussion with this review leading to an agreement on clinical read out parameters and monitoring intervals among S. suis research groups.
(© 2023. BioMed Central Ltd., part of Springer Nature.)

Infect Immun. 2002 Mar;70(3):1319-25. (PMID: 11854216)
Vet Microbiol. 2008 Apr 30;128(3-4):423-30. (PMID: 18068316)
Vet Microbiol. 2000 Jun 1;74(3):237-48. (PMID: 10808092)
J Am Assoc Lab Anim Sci. 2016;55(5):588-93. (PMID: 27657715)
Mol Microbiol. 2008 Dec;70(5):1120-35. (PMID: 18990186)
Animals (Basel). 2019 Jun 22;9(6):. (PMID: 31234475)
J Med Microbiol. 2014 Jun;63(Pt 6):824-830. (PMID: 24696517)
Arch Microbiol. 2009 Jan;191(1):23-33. (PMID: 18716756)
Vet Microbiol. 2001 Aug 20;81(4):331-44. (PMID: 11390114)
Expert Rev Vaccines. 2015;14(12):1587-608. (PMID: 26468755)
BMC Vet Res. 2022 Feb 28;18(1):81. (PMID: 35227252)
Front Vet Sci. 2016 Nov 14;3:100. (PMID: 27896270)
J Clin Microbiol. 2000 Mar;38(3):1156-60. (PMID: 10699012)
Vet Microbiol. 2002 Jan 3;84(1-2):155-68. (PMID: 11731168)
Pathogens. 2020 May 14;9(5):. (PMID: 32422856)
ILAR J. 2000;41(2):99-104. (PMID: 11406703)
Clin Diagn Lab Immunol. 2005 Apr;12(4):484-90. (PMID: 15817754)
Vet Res. 2018 Jun 15;49(1):48. (PMID: 29903042)
PLoS Med. 2006 May;3(5):e151. (PMID: 16584289)
Pathogens. 2019 Dec 06;8(4):. (PMID: 31817637)
Microbiology (Reading). 2001 Feb;147(Pt 2):271-280. (PMID: 11158344)
Vet Rec. 2001 Apr 14;148(15):473-7. (PMID: 11334073)
Lab Anim. 2020 Oct;54(5):469-478. (PMID: 31648591)
J Am Assoc Lab Anim Sci. 2015 Mar;54(2):120-32. (PMID: 25836957)
Emerg Microbes Infect. 2014 Jun;3(6):e45. (PMID: 26038745)
Transbound Emerg Dis. 2014 Dec;61(6):e35-43. (PMID: 23489297)
Vaccine. 2012 Feb 8;30(7):1379-87. (PMID: 22210137)
Infect Immun. 2006 Jan;74(1):305-12. (PMID: 16368985)
Can J Vet Res. 2005 Jul;69(3):236-40. (PMID: 16187555)
J Vet Med B Infect Dis Vet Public Health. 2002 Jun;49(5):211-5. (PMID: 12121040)
Can J Vet Res. 2004 Jan;68(1):66-70. (PMID: 14979438)
Pathogens. 2020 Jan 03;9(1):. (PMID: 31947746)
Vaccine X. 2019 Oct 10;3:100046. (PMID: 31709420)
Lab Anim. 2021 Jun;55(3):233-243. (PMID: 33215575)
J Vet Pharmacol Ther. 2015 Oct;38(5):475-81. (PMID: 25689130)
Pathogens. 2016 Aug 06;5(3):. (PMID: 27509526)
Infect Immun. 2006 Nov;74(11):6154-62. (PMID: 17057090)
BMC Vet Res. 2017 Jan 7;13(1):15. (PMID: 28061775)
Infect Immun. 2018 Feb 20;86(3):. (PMID: 29203546)
PLoS One. 2013 Apr 10;8(4):e61339. (PMID: 23593467)
Braz J Microbiol. 2012 Jul;43(3):993-1004. (PMID: 24031918)
ILAR J. 2000;41(2):105-13. (PMID: 11417495)
Acta Vet Scand. 2001;42(2):303-6. (PMID: 11503376)
Vet Res. 2021 Aug 25;52(1):112. (PMID: 34433500)
Front Microbiol. 2021 Jul 08;12:694103. (PMID: 34305859)
Physiol Behav. 2007 Oct 22;92(3):317-39. (PMID: 17234221)
Pathogens. 2017 Sep 27;6(4):. (PMID: 28953248)
ILAR J. 2006;47(4):364-9. (PMID: 16963816)
Ann Agric Environ Med. 2017 Dec 23;24(4):683-695. (PMID: 29284248)
Pathogens. 2017 Mar 22;6(1):. (PMID: 28327531)
Vet Microbiol. 2020 Apr;243:108653. (PMID: 32273000)
Infect Immun. 2005 May;73(5):3184-7. (PMID: 15845530)
Can J Vet Res. 2003 Jul;67(3):225-8. (PMID: 12889730)
BMC Vet Res. 2022 Dec 12;18(1):435. (PMID: 36510249)
FEMS Microbiol Lett. 2009 Jul;296(1):78-83. (PMID: 19459970)
Vet Immunol Immunopathol. 2012 May 15;146(3-4):191-200. (PMID: 22516423)
Clin Vaccine Immunol. 2007 Aug;14(8):937-43. (PMID: 17567767)
J Infect Dis. 2015 Jul 1;212(1):95-105. (PMID: 25525050)
Front Vet Sci. 2017 Apr 18;4:51. (PMID: 28459052)
Front Vet Sci. 2021 Aug 19;8:676002. (PMID: 34490389)
Comp Immunol Microbiol Infect Dis. 2016 Aug;47:52-9. (PMID: 27477507)
Trends Microbiol. 2017 Jul;25(7):585-599. (PMID: 28274524)
Res Vet Sci. 2017 Oct;114:482-488. (PMID: 28985615)
Vet Immunol Immunopathol. 2006 Sep 15;113(1-2):157-68. (PMID: 16774789)
Microb Pathog. 2010 Mar-Apr;48(3-4):103-9. (PMID: 19944142)
Res Vet Sci. 2009 Apr;86(2):200-5. (PMID: 18774148)
FEBS Lett. 2016 Nov;590(21):3772-3799. (PMID: 27539145)
BMC Microbiol. 2017 Mar 14;17(1):67. (PMID: 28292261)
Vaccine. 2015 May 5;33(19):2207-2212. (PMID: 25825330)
Vaccine. 2009 Aug 20;27(38):5209-13. (PMID: 19596417)
Asian-Australas J Anim Sci. 2016 Jan;29(1):149-56. (PMID: 26732339)
Lab Anim Res. 2020 Dec 9;36(1):45. (PMID: 33298163)
Transbound Emerg Dis. 2017 Apr;64(2):364-373. (PMID: 25955521)
J Vis Exp. 2021 Aug 21;(174):. (PMID: 34487115)
J Vet Med B Infect Dis Vet Public Health. 2002 Jun;49(5):240-4. (PMID: 12121045)
Vet Pathol. 2000 Mar;37(2):143-52. (PMID: 10714643)
Can J Vet Res. 2004 Jul;68(3):236-40. (PMID: 15352553)
Lab Anim. 2015 Oct;49(4):267-83. (PMID: 25957286)
J Virol. 2001 May;75(10):4889-95. (PMID: 11312360)
Sci Rep. 2021 Mar 22;11(1):6513. (PMID: 33753801)
J Microbiol. 2011 Dec;49(6):1000-11. (PMID: 22203565)
PLoS One. 2008 May 07;3(5):e2080. (PMID: 18461172)
Vaccine. 2011 Sep 2;29(38):6514-9. (PMID: 21767591)
J Bacteriol. 2009 Apr;191(8):2601-12. (PMID: 19181815)
Vet Res. 2021 Dec 19;52(1):145. (PMID: 34924012)
Vet Res Commun. 1997 Aug;21(6):381-407. (PMID: 9266659)
Vet Res. 2021 Oct 19;52(1):133. (PMID: 34666827)
Can J Vet Res. 2001 Jul;65(3):196-200. (PMID: 11480526)
Acta Vet Scand. 2010 May 05;52:29. (PMID: 20444254)
APMIS. 2001 Jun;109(6):412-8. (PMID: 11506472)
Vet Immunol Immunopathol. 2009 Dec 15;132(2-4):135-45. (PMID: 19505730)
Vet Pathol. 1995 Nov;32(6):648-60. (PMID: 8592800)
Int J Mol Sci. 2020 Jul 25;21(15):. (PMID: 32722502)
Clin Vaccine Immunol. 2009 Feb;16(2):200-8. (PMID: 19109449)
Vet Microbiol. 2001 Sep 3;82(1):69-80. (PMID: 11423197)
BMC Vet Res. 2014 Sep 16;10:199. (PMID: 25260642)
Lab Anim. 2016 Dec;50(6):414-417. (PMID: 27909190)
Infect Immun. 2015 Jan;83(1):441-53. (PMID: 25385801)
Vaccine. 2019 Apr 10;37(16):2194-2199. (PMID: 30902483)
Sci Rep. 2019 Oct 28;9(1):15429. (PMID: 31659179)
Acta Vet Scand. 2015 Feb 03;57:5. (PMID: 25644397)
PLoS One. 2022 May 5;17(5):e0266524. (PMID: 35511825)
Clin Vaccine Immunol. 2010 Oct;17(10):1589-97. (PMID: 20739502)
Front Vet Sci. 2016 Nov 28;3:108. (PMID: 27965968)
Virulence. 2018;9(1):1314-1337. (PMID: 30001174)
ILAR J. 2000;41(2):80-6. (PMID: 11406701)
Virulence. 2020 Dec;11(1):446-464. (PMID: 32419603)
PLoS Biol. 2020 Jul 14;18(7):e3000410. (PMID: 32663219)
Inflammation. 2018 Mar;41(2):368-377. (PMID: 29159765)
JMM Case Rep. 2017 May 3;4(5):e005093. (PMID: 29026620)
PLoS One. 2015 Apr 23;10(4):e0124086. (PMID: 25906258)
Saudi Pharm J. 2015 Jul;23(3):223-9. (PMID: 26106269)
Infect Immun. 2016 Jun 23;84(7):2059-2075. (PMID: 27113360)
Vet Res. 2015 Apr 19;46:45. (PMID: 25928761)
J Pain Res. 2014 May 08;7:227-36. (PMID: 24855386)
Animals (Basel). 2021 Apr 02;11(4):. (PMID: 33918530)
Microbiology (Reading). 2003 Jun;149(Pt 6):1399-1407. (PMID: 12777481)
PLoS One. 2012;7(11):e50987. (PMID: 23226442)
Pathogens. 2020 Jan 09;9(1):. (PMID: 31936553)

Keywords: Experimental infection; Humane endpoint; Pig; Refinement; Scoring; Streptococcus suis

Date Created: 20231005 Date Completed: 20231102 Latest Revision: 20231123

20240829

PMC10552360

10.1186/s12917-023-03735-9

37798634